KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 77 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $12,000 | +71.4% | 2,000 | +150.0% | 0.01% | 0.0% |
| Q4 2018 | $7,000 | -50.0% | 800 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $14,000 | 0.0% | 800 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $14,000 | +27.3% | 800 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $11,000 | +37.5% | 800 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $8,000 | -11.1% | 800 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $9,000 | +28.6% | 800 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $7,000 | -30.0% | 800 | 0.0% | 0.00% | -40.0% |
| Q1 2017 | $10,000 | +25.0% | 800 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |